Roxie Lynn Kneen, NP

Roxie Kneen practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Roxie Kneen's NPI, 1619363900, was assigned on April 13, 2015. Roxie Kneen holds California license NP95001901.

Roxie Kneen's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Roxie Kneen's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Roxie Kneen is also affiliated with MarinHealth Medical Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Roxie Kneen to 3 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Roxie Kneen practices, 3 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Roxie Kneen's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Roxie Kneen is licensed in California.

Dmand AI lists insomnia among the conditions Roxie Kneen treats.

CMS data shows 687 Medicare services from Roxie Kneen across 4 procedure codes in 2024, for 194 Medicare patients. Medicare paid $38,565 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 194 Medicare patients who saw Roxie Kneen in 2024. The largest group is 75 to 84, with 84 patients. 73% of them have high blood pressure, and 68% have high cholesterol. 26% are also on Medicaid. Their average risk score is 3.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Roxie Kneen's median patient age at 74, with 59% women.

In 2024, Roxie Kneen wrote 520 Medicare Part D claims for 119 patients. 63% of them were for generic drugs. CMS names the drug for 250 of them, across 12 drugs with 11 or more claims each, at $1,432,418 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Roxie Kneen for performance year 2024, reported as part of a group. Roxie Kneen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Roxie Kneen as offering telehealth.

CMS Open Payments shows 2 general payments to Roxie Kneen from 2 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $34.